Smith indicates use of the drug led him to develop a condition known as non-arteritic anterior ischemic optic neuropathy (NAION), which damages the optic nerves, leading to vision loss
While the primary binding occurs in the bloodstream with albumin (the most abundant protein in blood plasma), semaglutides action takes place in multiple locations throughout the body where GLP-1 receptors are present, including the: Pancreas, increasing the amount of insulin that our pancreas releases in response to food Gastrointestinal tract, slowing gastric emptying and promoting satiety (fullness) Brain, regulating our appetite and reducing the desire to eat more Together, all of this helps control blood glucose levels, suppress appetite, lower calorie intake and promote weight loss
Improved Detoxification Supports liver health and efficient toxin elimination
The question isnt whether GLP-1 medications workthey do
Bielach-Bazyluk A, Zbroch E, Mysliwiec H, et al
